logo
  •   Home
  • Applications
    • Indications
  • Business
  • EpiSwitch®
  • Products
    • EpiSwitch® Explorer Kit
    • EpiSwitch ® Service
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers

Oxford BioDynamics presents ALS signatures at NEALS.

October 11, 2017
|In Events
|By oxfordbiodynamics

Press release

British Biotech Spots DNA Changes that Help ALS Diagnosis – Labiotech

Oxford BioDynamics Demonstrates Ability To Predict Progression Of ALS – Morningstar

Northland Capital Partners View on the City – Oxford Biodynamics PLC – Proactive Investors

 

  • Prev
  • Next

Terms of Use / Site Map / Privacy Policy / Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571
© 2002-2020 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences